disodium [4-[pyridin-2-yl-(4-sulfonatooxyphenyl)methyl]phenyl] sulfate | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

disodium;[4-[pyridin-2-yl-(4-sulfonatooxyphenyl)methyl]phenyl] sulfate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 3 USDMF, 3 CEP/COS, 4 JDMF, 4 EU WC, 4 NDC API, 19 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

24 FDF Dossiers, 4 FDA Orange Book, 12 Europe, 3 Canada, 1 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;ORAL - 12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 12GM/BOT;3.5GM/BOT;10MG/BOT

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 1 DKSH, 1 Pharm-RX Chemical, 1 Faran Shimi Pharmaceutical, 2 Gangwal Healthcare, 1 Actylis, 1 Bioplus Life Sciences, 1 Pluviaendo

DIGITAL CONTENT

7 NEWS #PharmaBuzz

7 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 Finished Drug Prices, 1 Annual Reports

MARKET PLACE

15 APIs

15 APIs

PATENTS & EXCLUSIVITIES

5 US Patents

5 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 2 Others

$ Xls

Filters

Filters

FILTER :

filter Order Code Reset all filters

2 All

01 1S0785000

02 1Y0001104

filter CAS Number Reset all filters

filter Reference Standard Reset all filters

Product Main Page

01

EDQM, Council of Europe

Picosulfate for system suitability

American Pharma Summit

Not Confirmed

02

EDQM, Council of Europe

Sodium picosulfate

American Pharma Summit

Not Confirmed

Contact us
to update this info